baber/WOPTO huggingface dataset:
Patent ES-2133264-T1 (ES)
Title: Procedimiento de mando de la velocidad de un motor asincrono de induccion monofasico.
Inventor: ORSAT JEAN-MICHEL
IPC: H02P25/04
Filed: 1998-10-16
Abstract: PROCEDIMIENTO DE CONTROL DE LA VELOCIDAD DE UN MOTOR ASINCRONO CON INDUCCION MONOFASICA, CUYO ESTATOR ESTA PROVISTO DE UN BOBINADO PRINCIPAL (BP) Y CON UN BOBINADO AUXILIAR CONSTITUIDO POR SEMIBOBINADOS (B1, B2) ACOPLADOS MAGNETICAMENTE Y BOBINADOS EN SENTIDOS OPUESTOS, SEGUN EL CUAL SE ALIMENTA EL BOBINADO PRINCIPAL DIRECTAMENTE MEDIANTE UNA FUENTE DE CORRIENTE ALTERNA Y EL BOBINADO AUXILIAR MEDIANTE UNA CORRIENTE EMITIDA POR UN RECTIFICADOR CON DOBLE ALTERNANCIA Y MEDIANTE DOS INTERRUPTORES DE CONMUTACION (T1, T2) PARA GENERAR UNA CORRIENTE DESFASADA DE 90° EN EL BOBINADO AUXILIAR. EL PROCEDIMIENTO CONSISTE EN VARIAR EL PAR DEL MOTOR MODIFICANDO EL TIEMPO DE CIERRE/APERTURA DE AL MENOS UNO DE LOS INTERRUPTORES.
Patent CY-1107033-T1 (CY)
Title: Συνθεση στη μορφη σπρεϊ η οποια περιλαμβανει ενα συνδυασμο προπιονικης κλομπεταζολης και καλσιτριολης, μια αλκοολικη φαση και μια ελαιωδη φαση
Inventor: WILLCOX NATHALIE
IPC: A61K9/00
Filed: 2007-12-06
Abstract: Η εφεύρεση αφορά σε μια άνυδρη σύνθεση στη μορφή ενός σπρέι που περιλαμβάνει ένα συνδυασμό προπιονικής κλομπεταζόλης και καλσιτριόλης σαν φαρμακευτικά δραστικό συστατικό, μια αλκοολική φάση και μια ελαιώδη φάση, σε ένα φυσιολογικά αποδεκτό μέσο, στη μέθοδο για την παρασκευή της και στη χρήση της σε καλλυντικά και τη δερματολογία.
Patent CY-1107394-T1 (CY)
Inventor: KASEL TORSTEN DR
IPC: G06Q30/00
Filed: 2008-04-15
Abstract: The arrangement has a detection device (14) for detecting an identifier (6) attached to the objects (1). An identifier cancellation device (16) is arranged after the detection device, with which the identifiers attached to the objects can be simply canceled and/or destroyed after detection. The detection device is connected to an evaluation device for evaluating the detected data. AN Independent claim is also included for the following: a method of retrieving objects, especially containers in the drinks industry.
Patent CY-1108719-T1 (CY)
Inventor: BAUMRUKER THOMAS
IPC: A61K45/00
Filed: 2009-01-27
Abstract: Provided is a method for treating solid tumors, e.g tumor invasiveness, and particularly inhibiting or controlling deregulated angiogenesis, using a sphingosine-1-phosphate receptor agonist, optionally in combination with a chemotherapeutic agent. The invention also comprises a combination of a sphingosine-1-phosphate receptor agonist with a chemotherapeutic agent.
Patent CY-1110915-T1 (CY)
Inventor: HAREL-BELLAN ANNICK
IPC: C12N15/113
Filed: 2010-11-17
Abstract: Double-stranded oligonucleotides (I) consisting of two complementary strands (Ia; Ib), each having at one of their 3' and 5' ends 1-5 unpaired nucleotides, forming single-stranded overhangs, are new. One of (Ia) and (Ib) is complementary to a target sequence, of DNA or RNA, that is to be specifically repressed. ACTIVITY : Cytostatic; Virucide; Anti-HIV; Neuroprotective; Ophthalmological; Antidiabetic; Antipsoriatic; Antirheumatic; Antiarthritic. The oligonucleotide hybrid (A) prepared from sequences of formulae ggggaggcagccauugagacTT gucucaauggcugccuccccTT (lower case indicates ribonucleotides and upper case deoxyribonucleotides) was designed to target the junction of the PML/RARalpha fusion gene associated with promyelocytic leukemia. It (500 ng) was introduced into NIH 3T3 cells, co-transfected with a vector (100 ng) that expressed the PML/RARalpha fusion. Western blotting analysis after 48 hours showed greatly reduced expression of the fusion protein, relative to a control without (A). MECHANISM OF ACTION : Antisense inhibition of gene expression.
Patent CY-1112352-T1 (CY)
Inventor: LEOHR JENNIFER K
IPC: G01N33/92
Filed: 2011-12-02
Abstract: Methods, systems, and computer program products using TRL V6 as a biomarker for the modulation of triglyceride and/or lipoprotein metabolism in a mammal induced by an investigational weight loss pharmaceutical agent. The biomarker may be used for predetermining if an individual patient will likely respond favorably to a given weight loss pharmaceutical agent and/or for testing a pharmaceutical agent's ability to modulate triglyceride and/or lipoprotein metabolism in a mammal.
Patent CY-1118442-T1 (CY)
Title: Μεθοδοι αγωγης δια της χρησεως εκλεκτικων αναστολεων bcl-2
Inventor: ELMORE STEVEN
IPC: A61P37/00
Filed: 2016-12-13
Abstract: Η παρούσα εφεύρεση αφορά σε μεθόδους αγωγής του συστηματικού ερυθηματώδους λύκου, της νεφρίτιδας του λύκου ή του συνδρόμου Sjogren με ενώσεις που αναστέλλουν εκλεκτικά τη δραστικότητα των αντιαποπτωτικών πρωτεϊνών Bcl 2. Συγκεκριμένα, η τρέχουσα εφεύρεση στοχεύει στην αγωγή με ενώσεις που αναστέλλουν εκλεκτικά τη δραστικότητα των πρωτεϊνών Bcl-2 με μικρότερη συνάφεια αναστολής της δραστικότητας άλλων πρωτεϊνών της οικογενείας BCL-2, συμπεριλαμβανομένης της Bcl-XL.
Patent CY-1119465-T1 (CY)
Title: Αντισωματα συνδεσης ανθρωπινου cgrp υποδοχεα
Inventor: BOONE THOMAS C
IPC: C07K16/28
Filed: 2017-08-28
Abstract: Παρέχονται πρωτεΐνες σύνδεσης-αντιγόνου που συνδέονται προς ανθρώπινο CGRP υποδοχέα (CGRP R). Παρέχονται επίσης νουκλεϊνικά οξέα που κωδικοποιούν την πρωτεΐνη σύνδεσης αντιγόνου, φορείς και κύτταρα που κωδικοποιούν αυτά. Οι πρωτεΐνες σύνδεσης-αντιγόνου μπορεί να παρεμποδίζουν σύνδεση του CGRP R προς CGRP και είναι χρήσιμες σε έναν αριθμό σχετικών με CGRP R διαταραχών, που συμπεριλαμβάνει τη θεραπεία ή/και την αποτροπή κεφαλαλγιών ημικρανίας.
Patent CY-1120232-T1 (CY)
Title: 2-αμινο-6-φθορο-ν-(5-φθορο-4-(4-(4-(οξεταν-3-υλ)πιπεραζινο-1-καρβονυλ)πιπεριδιν-1-υλ)πυριδιν-3-υλ)πυραζολο[1,5αλφα]πυριμιδινο-3-καρβοξαμιδιο ως αναστολεας κινασης atr
Inventor: AHMAD NADIA
IPC: C07D487/04
Filed: 2018-05-18
Abstract: Η παρούσα εφεύρεση αναφέρεται σε ενώσεις χρήσιμες ως αναστολείς κινάσης πρωτεΐνης ATR. Η εφεύρεση αναφέρεται, επίσης, σε φαρμακευτικώς αποδεκτές συνθέσεις, οι οποίες περιέχουν τις ενώσεις αυτής της εφεύρεσης, μεθόδους θεραπευτικής αγωγής διαφόρων ασθενειών, διαταραχών και καταστάσεων με χρήση των ενώσεων αυτής της εφεύρεσης, διαδικασίες για την παρασκευή των ενώσεων αυτής της εφεύρεσης, ενδιάμεσα για την παρασκευή των ενώσεων αυτής της εφεύρεσης και μεθόδους χρήσης των ενώσεων σε in vitro εφαρμογές, όπως η μελέτη κινασών σε βιολογικά και παθολογικά φαινόμενα, η μελέτη οδών μεταγωγής ενδοκυτταρικών σημάτων που διαμεσολαβείται από τέτοιες κινάσες και η συγκριτική αξιολόγηση νέων αναστολέων κινασών. Οι ενώσεις αυτής της εφεύρεσης έχουν τύπο (I) ή ένα φαρμακευτικώς αποδεκτό άλας, όπου οι μεταβλητές είναι όπως ορίζονται στο παρόν. Επιπλέον, οι ενώσεις αυτής της εφεύρεσης έχουν τύπο (Ι-Α) ή ένα φαρμακευτικώς αποδεκτό άλας, όπου οι μεταβλητές είναι όπως ορίζονται στο παρόν.
Patent CY-1120754-T1 (CY)
Title: Mh υδατικο επιθεμα
Inventor: MORI TATSUYA
IPC: A61K9/70
Filed: 2018-08-06
Abstract: Εάν λιδοκαΐνη συντίθεται από μη υδατικό επίθεμα, η ικανότητα συγκολλήσεως του παρασκευάσματος τείνει να καθίσταται χαμηλότερη, καθώς η ποσότητα στη σύνθεση της λιδοκαΐνης είναι υψηλότερη. Είναι διαδεδομένη η διάλυση της λιδοκαΐνης εντός παράγοντα διαλύσεως προκειμένου να συντεθεί η λιδοκαΐνη σε επίθεμα και να απελευθερώσει αποτελεσματική ποσότητα στο δέρμα. Ωστόσο, εάν η ποσότητα του παράγοντα διαλύσεως αυξηθεί, η ικανότητα συγκολλήσεως καθίσταται ιδιαιτέρως χαμηλότερη, κατά τρόπο ώστε μία μακροχρόνια συγκόλληση είναι δύσκολη. Για την επίλυση αυτού του προβλήματος, παρέχεται ένα μη υδατικό επίθεμα που περιλαμβάνει λιδοκαΐνη και/ή το αντιδρόν της και έναν παράγοντα διαλύσεως που περιέχονται σε μία βάση γύψου, όπου ο γύψος συγκρατείται μέσω υποστηρίγματος, του οποίου η αντοχή μετά από τάνυση κατά 50% κατά τη διαμήκη διεύθυνση είναι μικρότερη από 2.000g/50mm και ενός ελαστικού υφάσματος προσανατολισμένου σε δύο άξονες.
Patent CY-1122608-T1 (CY)
Title: Θεραπευτικη αγωγη
Inventor: DAVIES BARRY ROBERT
IPC: A61P35/00
Filed: 2019-12-17
Abstract: Η παρούσα εφεύρεση αναφέρεται σε ένα συνδυασμό που περιλαμβάνει το (5)-4-αμινο-Ν-(1-(4-χλωροφαινυλο)-3-υδροξυπροπυλο)-1-(7Η-πυρρολο[2,3-d]πυριμιδιν-4-υλο) πιπεριδινο-4-καρβοξαμίδιο, ή ένα φαρμακευτικά αποδεκτό άλας αυτού, στο εξής «Ένωση (I)», και μια ταξάνη. Οι ταξάνες περιλαμβάνουν εδραιωμένα φάρμακα κατά του καρκίνου όπως η ντοσεταξέλη (Taxotere™) και η πακλιταξέλη (Taxol™). Τέτοιοι συνδυασμοί μπορεί να είναι χρήσιμοι στην αγωγή ή την προφύλαξη από τον καρκίνο. Η εφεύρεση αναφέρεται επίσης σε μια φαρμακευτική σύνθεση που περιλαμβάνει μια τέτοια Ένωση (I) και μια ταξάνη. Η εφεύρεση αναφέρεται περαιτέρω σε μια μέθοδο αγωγής που περιλαμβάνει ταυτόχρονη, διαδοχική ή ξεχωριστή χορήγηση της Ένωσης (I) και μιας ταξάνης, σε ένα θερμόαιμο ζώο, όπως ο άνθρωπος. Η εφεύρεση αναφέρεται επίσης σε ένα κιτ που περιλαμβάνει την Ένωση (I) και μια ταξάνη, προαιρετικά με οδηγίες χρήσης.
Patent CY-1123564-T1 (CY)
Title: Ενωσεις τυπου τρικυκλικων διβενζοθειαζεπινων για χρηση στη θεραπεια της διαταραχης cdkl5
Inventor: CAVALLA DAVID
IPC: A61K31/554
Filed: 2020-09-22
Abstract: Ενώσεις τρικυκλικών διβενζοθειαζεπινών για χρήση στην αγωγή της διαταραχής CDKL5. Συγκεκριμένα, μια ένωση του Χημικού Τύπου Ι, ή ένα φαρμακευτικώς ή κτηνιατρικώς αποδεκτό άλας εξ αυτής, ή ένα φαρμακευτικώς ή κτηνιατρικώς επιδιαλυτωμένο άλας της όποιας οντότητας για χρήση στην αγωγή της διαταραχής CDKL5 σε ένα θηλαστικό, όπου μια ένωση του Χημικού Τύπου I περιλαμβάνει: (i) χημικό τύπο 1 ή ένα φαρμακευτικώς ή κτηνιατρικώς αποδεκτό άλας εξ αυτής, ή ένα φαρμακευτικώς ή κτηνιατρικώς αποδεκτό επιδιαλυτωμένο άλας της όποιας οντότητας, όπου: τα R1 και R3 αναπαριστούν κάθε ένα ανεξαρτήτως, σε κάθε μια εμφάνιση όταν χρησιμοποιούνται εις το παρόν, Η ή C1 έως C5 αλκύλιο˙ το R2 αναπαριστά αλοομάδα˙ τα R4 και R5 αναπαριστούν κάθε ένα ανεξαρτήτως Η˙ το R6 αναπαριστά -C(O)OR9˙ το Χ αναπαριστά CH2, Ο ή S˙ το R9 αναπαριστά Η ή C1 έως C5 αλκύλιο˙ και, το m είναι ένας ακέραιος αριθμός από 1 έως 6 συμπεριλαμβανομένου.
Patent HR-P20100345-T1 (HR)
Title: Crystalline forms of macrolide compounds endowed with antiinflammatory activity
Inventor: MARAGNI PAOLO
IPC: A61P29/00
Filed: 2010-06-18
Abstract: The present invention relates to macrolide compounds endowed with antiinflammatory activity and more particularly relates to new stable crystalline forms of a macrolide derivative with antiinflammatory activity, processes for the preparation of such forms, pharmaceutical compositions containing them as active ingredient and the use of said crystalline forms for the treatment of inflammatory diseases.
Patent HR-P20110552-T1 (HR)
Title: 1, 2, 3-triazole derivatives for use as stearoyl-coa desaturase inhibitors
Inventor: BOUILLOT ANNE MARIE JEANNE
IPC: A61K31/4192
Filed: 2011-07-25
Abstract: The present invention relates to substituted triazole compounds of the formula (I) and pharmaceutically acceptable salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds for modulating SCD activity.
Patent HR-P20120650-T1 (HR)
Title: Method of transmitting and receiving a signal and apparatus for transmitting and receiving a signal
Inventor: HO TAEK HONG
IPC: H04L27/26
Filed: 2012-08-09
Abstract: The present invention relates to method of transmitting and receiving broadcasting signal and a corresponding apparatus. One aspect of the present invention relates to a method of receiving broadcasting signal, wherein a C2 delivery system descriptor including an identifier of a PLP and an identifier of a C2 system in a TS loop of the NIT maps a transport stream to the data PLP in a data slice of the C2 system.
Patent SI-1500942-T1 (SI)
Title: Device for voltage testing of cables and cable fittings by a very low frequency voltage
Inventor: PFLUGBEIL WILFRIED
IPC: G01R31/02
Filed: 2004-07-19
Abstract: The voltage testing device has a control stage and a HV stage, provided by a setting transformer (1), with a positioning drive (2), coupled via a switch (3) with the primary winding of a HV transformer (4). The secondary winding of the HV transformer is coupled on one side to the insulation of the tested cable (10) via a shunt (8) and to the core of the tested cable via a measuring voltage divider (9), the opposite side of the secondary winding coupled to the cable core via a pair of anti-parallel rectifiers (5,6) and a HV switching device (7). The tested cable is connected in parallel with a discharge device (11).
Patent SI-1571173-T1 (SI)
Title: Process for producing polyamide-12 powder with high melting point
Inventor: LOYEN KARINE
IPC: C08K3/00
Filed: 2005-02-28
Abstract: Method for preparing polyamide-12 powder (A) by anionic polymerization of lauryl lactam (I) dissolved in a solvent in which (A) is insoluble. Method for preparing polyamide-12 powder (A) by anionic polymerization of lauryl lactam (I) dissolved in a solvent in which (A) is insoluble. Polymerization is done in presence of (a) a catalyst or activator (II); (b) a finely divided organic or inorganic filler (III), at not over 1.5 g per kg of (I), and (c) amide R1NHCOR2 (IV), at 0.001-0.03 mole per kg (I). R1 : aryl, alkyl, cycloalkyl, R3CONH or R3O; R2 and R3 : alkyl, aryl or cycloalkyl .
Patent SI-1933652-T1 (SI)
Title: Gravure-printed banded cigarette paper
Inventor: SHERWOOD TIMOTHY S
IPC: A24C5/00
Filed: 2006-08-14
Abstract: A cigarette and cigarette paper have a plurality of multilayer bands formed by printing a highly viscous aqueous film-forming composition. After heating the composition to lower its viscosity, the bands are applied to the cigarette paper by gravure printing the composition. The composition is quenched and gelatinized by contact with the cool cigarette paper reducing absorption of water by the paper and reducing wrinkling, cockling, and waviness. Multiple gravure printed layers may be used to form the bands.
Patent SI-2167150-T1 (SI)
Title: Porous composite material, preparation process thereof and use to realize tissue engineering devices
Inventor: BIGI ADRIANA
IPC: A61L27/00
Filed: 2008-06-27
Abstract: The present invention refers to a porous composite material, wherein at least one interdispersed biopolymer is present, with a calcium-phosphate mineral component comprising from 50 w/% to 95 w/% of α-tricalcium phosphate (α-TCP, α-Ca3(PO4)2) and from 5 w/% to 50 w/% of octacalcium phosphate (OCP, Ca8H2(PO4)6—5H2O), to the total weight of the mineral component. Such combination of α-TCP and OCP allows an in vivo faster resorption rate and thereby a faster formation of new bone tissue having a low cristallinity mineral component with nanocrystal structure, features very similar to those of biological apatites. This porous composite material may find application as bone and/or osteal-chart ilagineous substitute (scaffold) and in producing tissue engineering devices.
Patent SI-2164492-T1 (SI)
Title: Trans-4-?í2-?á4-(2,3-dichlorophenyl)-piperazin-1-yl?å-ethyl?ç-N,N-dimethylcarbamoyl-cyclohexylamine for treating schizophrenia
Inventor: LASZLOVSZKY ISTVAN
IPC: A61K31/00
Filed: 2008-05-19
Abstract: The present invention relates to use of (thio)-carbamoyl-cyclohexane derivatives, particularly trans-4-{2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl}-N,N-dimethylcarbamoyl-cyclohexylamine and pharmaceutically acceptable salts thereof in the manufacture of a medicament for the treatment of schizophrenia. Furthermore, the present invention relates to the treatment of schizophrenia through the administration of (thio)-carbamoyl cyclohexane derivatives, particularly trans-4-{2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl}-N,N-dimethylcarbamoyl-cyclohexylamine and pharmaceutically acceptable salts thereof.
Patent SI-3004106-T1 (SI)
Title: Dual selective pi3 delta and gamma kinase inhibitors
Inventor: VAKKALANKA SWAROOP K V S
IPC: C07D473/00
Filed: 2014-06-04
Abstract: The present invention relates to dual delta (δ) and gamma (γ) PI3K protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of Pi3K kinase mediated diseases or disorders with them.
Patent DE-3750470-T2 (DE)
Inventor: HUDGENS STEPHEN J
IPC: H01J37/32
Filed: 1987-12-14
Granted: 1995-02-09
Abstract: A method of depositing a substantially hydrogen free or controlled hydrogen content multi-element alloy film on a substrate. The method utilizes a microwave excited plasma of a hydrogen free precursor gas to deposit a hard, adherent coating. The method comprises providing a substrate to be coated in a vacuum deposition chamber, with a source of microwave energy coupled to the vacuum deposition chamber. A substantially hydrogen free reaction gas precursor composition is introduced into the reaction chamber at a pressure corresponding substantially to a pressure minimum of the modified Paschen curve for the reaction gas precursor composition. Activation of the source of microwave energy excites the reaction gas precursor composition, in this way forming a plasma in the vacuum deposition chamber to deposit a substantially hydrogen free or controlled hydrogen content multi-element alloy film on the substrate.
Patent DE-3780570-T2 (DE)
Inventor: BERG LARS OLOF
IPC: B62D27/06
Filed: 1987-11-03
Granted: 1993-02-18
Abstract: An arrangement for detachably mounting a platform stanchion on the edge surface of a truck platform comprises an attachment (10) which is permanently secured to said edge surface. The attachment has an upper and a lower horizontally projecting yoke (12 and 13, respectively). The rear wall (15) of the stanchion has at its lower end a tongue (20) insertable into the lower yoke (13), and an opening (25) adapted to be moved over the upper yoke (12), such that a locking key (23) can be pushed through the yoke on the stanchion side facing away from the edge surface. The wall surface of the stanchion facing said edge surface has a recess and, within the confines of said recess, a projection (22). The recess and the projection are dimensioned to receive the attachment (10) in the recess, such that the projection (22) extends through a hole in the attachment (10). As a result, the attachment surface connected with the platform edge, the stanchion wall surface on both sides of said recess, and the end surface of the projection (22) facing the platform edge lie in the same plane.
Patent DE-3879080-T2 (DE)
Inventor: RADEBAUGH WESLEY
IPC: A61K9/20
Filed: 1988-04-22
Granted: 1993-07-15
Abstract: An ibuprofen-sustained release tablet or tablet layer is formed by making a wet granulation using povidone (PVP) in alcohol as the granulating fluid which is mixed with ibuprofen ethylcellulose, a wicking agent e.g. microcrystalline cellulose, an erosion promoter e.g. pregelatinized starch, then drying and milling the granulation and blending with dry powdered erosion promotor, wicking agent, lubricant e.g. magnesium stearate and glidant e.g. silicon dioxide, and compressing the resultant granulation, which upon administration results in a long-lasting slow and relatively regular incremental release of the ibuprofen.
Patent DE-3882613-T2 (DE)
Inventor: LUNTS LAWRENCE HENRY CHARLES
IPC: C07D215/14
Filed: 1988-08-10
Granted: 1994-07-21
Abstract: The invention provides compounds of the general formula (I) <CHEM>  and physiologically acceptable salts and solvates thereof, wherein  Q represents a chlorine atom or a trifluoromethyl group; X represents a bond, or a C1-6alkylene, C2-6alkenylene or C2-6alkynylene chain, and Y represents a bond, or a C1-6alkylene, C2-6alkenylene or C2-6alkynylene chain with the proviso that the sum total or carbon atoms in the chains X and Y is not more than 10, and the chains XCH2 and CH2Y may each be optionally substituted by one or two C1-3alkyl groups, or, when one carbon atom is substituted by two alkyl groups, these may be linked to form an alkylene group;  R represents a hydrogen atom or a C1-3alkyl group; R<1> and R<2> each represent a hydrogen atom or a C1-3alkyl group, with the proviso that the sum total of carbon atoms in R<1> and R<2> is not more than 4; and Het represents a benzoheteroaryl or a monocyclic heteroaryl group wherein the heteroaryl group is 5 or 6 membered and contains 1, 2 or 3 hetero atoms, one of which is a nitrogen atom and the other(s) is (are) nitrogen, oxygen or sulphur atom(s), and the group Het may optionally be substituted by one or two groups selected from C1-4alkyl, C1-4alkoxy, hydroxy, halogen, -NR<3>R<4> and -COR<8>; where R<3> and R<4> each represent a hydrogen atom or a C1-4alkyl group or -NR<3>R<4> forms a saturated heterocyclic amino group which has 5-7 ring members and optionally contains in the ring one or more atoms selected from -O- or -S- or a group -NH- or -N(CH3)-; and  R<8> represents hydroxy, C1-4alkoxy or -NR<3>R<4>;  with the proviso that   (i) when Het represents a pyridyl group substituted by the group -NR<3>R<4> or -COR<8> and Q is a chlorine atom, or (ii) when Het represents a pyridyl group optionally substituted by one or two groups selected from halogen, hydroxy, C1-3alkyl and C1-3alkoxy, and Y represents a bond or a C1-4alkylene, C2-4alkenylene or C2-4alkynylene chain, then, in both cases, R represents a C1-3alkyl group and/or at least one of the chains -XCH2- and -CH2Y- is substituted by one or two C1-3alkyl groups.   The compounds have a stimulant action at  beta 2-adrenoreceptors and may be used in the treatment of diseases associated with reversible airways obstruction such as asthma and chronic bronchitis.
Patent TR-199901702-T2 (TR)
Inventor: GAUTIER JEAN-CLAUDE
IPC: A61P25/00
Filed: 1997-12-04
Abstract: Mevcut bulus, formül I N-sulfonilindolin hidrofobik türevlerinin çözünürlügü için, suda emülsiflesebilen veya mikro emülsiflesebilen bir susuz çözücü/dengeleyici sistemle ilgili olup özelligi, amfifilik bilesikler, ve iyonik olmayan hidrofilik yüzey aktif maddeleri ve hem amfifilik ve hem de yüzey aktif özellikleri olan iyonik olmayan hidrofilik bilesiklerden seçilen bir veya daha fazla bilesen içermesidir, yani, bahsedilen sistem ya en az bir amfifilik bilesik ve iyonik olmayan hidrofilik yüzey aktif karisimi, veya en az bir hem yüzey aktif ve amfifilik özelikleri olan iyonik olmayan hidrofilik bilesik içerir.
Patent DE-60001690-T2 (DE)
Inventor: WHITHAM CHRISTOPHER
IPC: D06P1/18
Filed: 2000-01-20
Granted: 2003-10-16
Abstract: The invention provides a dye composition for dyeing fibres comprising (a) an azo dye of formula (II) or a slat thereof, and (b) an azo dye of formula (III) or a salt thereof. The invention provides navy and black dye compositions, especially suitable for dyeing secondary cellulose acetate fibres, with superior fastness properties than known navy/black dyes. Preferably, the α-crystal form of dye (III) is used, which has greater solubility and achieves quicker dyeing than the commonly-used β and γ forms of (III) when dyeing cellulose acetate at 60-95°C. A new method of making the α form is disclosed.
Patent DE-60003623-T2 (DE)
Inventor: PERTUSI PIERLUIGI
IPC: B62D55/084
Filed: 2000-11-29
Granted: 2004-02-05
Abstract: A crawler vehicle, in particular a farm tractor (1), characterized by having a transverse supporting device (28) in turn having a first member (29a) connected mechanically to a box-shaped first longitudinal beam (8a), a second member (29b) connected mechanically to a box-shaped second longitudinal beam (8b), and a third member (29c) suspended centrally from the frame (3); the positions of the first member (29a) and the second member (29b) being adjustable and fixable with respect to the third member (29c) by means of respective adjusting and fastening means (30a, 30b) to adapt the overall length of the device (28) to the width (H) of the vehicle (1). <IMAGE>
Patent DE-60003713-T2 (DE)
Inventor: OLSSON MATS
IPC: B01D53/26
Filed: 2000-10-12
Granted: 2004-04-15
Abstract: Air in a compressed air system is cleaned by consecutively passing the air through a pre-filter (6), silica gel with large pores (7), silica gel with fine pores (8), a molecular sieve (9), and a fine filter (10).